Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized magnesium sulfate for pediatric acute asthma
NCT01429415Phase 2Completed
- Sponsor
- SickKids
- Start
- Sep 2011
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of magnesium sulfate in asthma, sponsored by SickKids. Primary endpoint: Hospitalization of Subject at 24 hours. Started Sep 2011; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01429415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01429415.